TetraLogic Pharmaceuticals Announces Decision to Grant Japanese Patent on Birinapant
1/29/2013 9:48:14 AM
More...
|
TetraLogic Pharmaceuticals Announces Presentation on Smac Mimetic Birinapant at American Society of Hematology Annual Meeting
12/10/2012 9:44:31 AM
More...
|
TetraLogic Pharmaceuticals' Smac Mimetic Birinapant Selected for Oral Presentation at the 17th Japanese Foundation for Cancer Research – International Symposium on Cancer Chemotherapy
12/6/2012 11:11:12 AM
More...
|
TetraLogic Pharmaceuticals Granted Third U.S. Patent on Birinapant
10/9/2012 9:45:28 AM
More...
|
Clinical Pharmacokinetic Data on TetraLogic Pharmaceuticals' Lead Smac Mimetic Birinapant Presented at American Society of Clinical Oncology
6/4/2012 11:13:32 AM
More...
|
TetraLogic Pharmaceuticals Founder John Gill Receives Semper Fidelis Award
4/23/2012 10:58:14 AM
More...
|
TetraLogic Pharmaceuticals Announces Presentation of Preclinical Data on Birinapant (TL32711) in Pancreatic Cancer and Lymphoma at the 103rd American Association for Cancer Research Annual Meeting 2012
4/3/2012 11:43:33 AM
More...
|
TetraLogic Pharmaceuticals Appoints C. Glenn Begley as Senior Vice President Research and Development
3/15/2012 6:32:01 AM
More...
|
TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology Annual Meeting
12/12/2011 9:21:35 AM
More...
|
TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
12/5/2011 11:02:04 AM
More...
|
|